Prevalence of HIV and injecting drug use in men entering Liverpool prison.
作者信息
Bellis M A, Weild A R, Beeching N J, Mutton K J, Syed Q
机构信息
Department of Public Health, University of Liverpool.
出版信息
BMJ. 1997 Jul 5;315(7099):30-1. doi: 10.1136/bmj.315.7099.30.
Abstract
摘要
相似文献
1
Prevalence of HIV and injecting drug use in men entering Liverpool prison.
BMJ. 1997 Jul 5;315(7099):30-1. doi: 10.1136/bmj.315.7099.30.
2
Prevalence of drug injecting among prison inmates.
Commun Dis Public Health. 2000 Dec;3(4):308-9.
3
Drug injection and HIV prevalence in inmates of Glenochil prison.
BMJ. 1995 Feb 4;310(6975):293-6. doi: 10.1136/bmj.310.6975.293.
4
Harm reduction measures and injecting inside prison versus mandatory drugs testing: results of a cross sectional anonymous questionnaire survey. The European Commission Network on HIV Infection and Hepatitis in Prison.
BMJ. 1997 Jul 5;315(7099):21-4. doi: 10.1136/bmj.315.7099.21.
5
Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey.
Commun Dis Public Health. 2000 Jun;3(2):121-6.
6
HIV infection among male prisoners in South Australia, 1989 to 1994.
Aust N Z J Public Health. 1997 Oct;21(6):572-6. doi: 10.1111/j.1467-842x.1997.tb01757.x.
7
Survey of French prison found that injecting drug use and tattooing occurred.
BMJ. 1998 Mar 7;316(7133):777. doi: 10.1136/bmj.316.7133.777.
8
Survey of risk behaviour and HIV prevalence in an English prison.
Int J STD AIDS. 1999 Jul;10(7):464-6. doi: 10.1258/0956462991914474.
9
Injecting drug use in prison: prevalence and implications for needle exchange policy.
Int J Prison Health. 2015;11(1):17-29. doi: 10.1108/IJPH-09-2014-0032.
10
People who inject drugs in prison: HIV prevalence, transmission and prevention.
Int J Drug Policy. 2015 Feb;26 Suppl 1:S12-5. doi: 10.1016/j.drugpo.2014.10.012. Epub 2014 Dec 1.
引用本文的文献
1
Correlates of Mandrax use and condom beliefs in preventing sexually transmitted infections among a cohort of South African prison inmates.
Int Health. 2016 Mar;8(2):142-7. doi: 10.1093/inthealth/ihv048. Epub 2015 Aug 27.
2
Prevalence of antibodies to human immunodeficiency virus, hepatitis B, and hepatitis C in prisoners in Libya.
Libyan J Med. 2012;7:19713. doi: 10.3402/ljm.v7i0.19713. Epub 2012 Dec 18.
3
Socio-demographic determinants of coinfections by HIV, hepatitis B and hepatitis C viruses in central Italian prisoners.
BMC Infect Dis. 2007 Aug 30;7:100. doi: 10.1186/1471-2334-7-100.
4
Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan--Iran.
World J Gastroenterol. 2005 Jul 14;11(26):4085-9. doi: 10.3748/wjg.v11.i26.4085.
5
Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey.
BMJ. 2000 Jul 8;321(7253):78-82. doi: 10.1136/bmj.321.7253.78.
Zotero 插件